drugset / Trial / NCT05100199
A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a Phase 2, dose ranging study to evaluate the safety of OnabotulinumtoxinA X and to compare the efficacy of OnabotulinumtoxinA X and placebo for the treatment of Glabellar Lines in adult participants with moderate to severe GL.
Timeline
- Start
- 2021-10-06
- Primary completion
- 2022-12-02
- Completion
- 2022-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OnabotulinumtoxinA X | Protein / enzyme biologic | — | Other |
Indications
No indication recorded.